Las Vegas

COVID treatment pills expect FDA approval this week – Las Vegas, Nevada

Las Vegas, Nevada 2021-12-22 10:39:03 –

Las Vegas (KTNV) — Game changers in the fight against COVID-19 could come as early as this week. According to Bloomberg News, two pharmaceutical companies may obtain an FDA emergency use authorization for tablets to treat COVID-19.

Pfizer and Merck state that oral treatments may help prevent hospitalization and death from COVID-19.

The Southern Nevada Health District currently reports that more than 23,055 patients are hospitalized for COVID. The test positive rate in Nevada is 7.6%.

Albert Bourla, CEO and Chairman of Pfizer, states that the drug is intended solely to treat COVID at home at the onset of symptoms. Bourla says vaccines are still the primary tool for overcoming a pandemic.

“When there is a peak of this illness, when the waves come, the hospital is really crowded, which causes serious problems in the healthcare system,” Bourla said. “With this pill, we expect 10 out of 10 people to go to the hospital. One will go, and no one will die.”

Merck reports that the drug is 30% effective, while Pfizer states that the drug is 90% effective. The United States has contracts to purchase 5 million courses of Merck and 10 million courses of Pfizer pills. If the company is approved by the FDA, the drug may be available in the United States by the end of the year.



Source link

Back to top button